Real-World Study of Intranasal Cell Therapy for Brain Injuries
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Injuries & trauma, Mental health clinical trials.
This study follows people who receive intranasal stem cell or exosome therapy (tiny packages from special cells) for brain or neurological conditions like stroke, brain injury, or cerebral palsy. Researchers track how well the treatment works by measuring inflammation markers in the blood and monitoring clinical improvements over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed neurological condition such as traumatic brain injury, stroke, cerebral palsy, or similar brain disorder
- You are receiving or have scheduled intranasal MuSE stem cell or exosome therapy as part of your medical care
- You can have a blood test to measure inflammation before treatment and during follow-up visits
- Your brain condition has been stable for at least 2 weeks before starting the study
- You do not have an active infection at the time of enrollment
- You are not taking strong immune-suppressing medications that could affect study measurements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.
This study is looking at people with traumatic brain injuries to improve how they are treated. If you join, you will get an MRI and other tests within the first two days after your injury, and the researchers will track your recovery over time.
This study follows people who have already chosen to receive MUSE stem cell therapy for their traumatic brain injury. It aims to track their safety and outcomes over time to learn if this treatment helps.
This study tests the safety of giving stem cells from umbilical cord blood through an IV to people who have had a traumatic brain injury (TBI). The goal is to see if this treatment is safe and might help with recovery.
Hear when a new Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.